Broadening Clinical Perspectives on Inferior Alveolar Nerve Blocks
Course Units: 2Issue Date: February 1, 2023Expiration Date: February 28, 2026Authors: Arthur C. DiMarco, DMD; Lorie Speer, RDH, MSDH; and Kathy Bassett, RDH, MEd
Oral Health Professionals’ Role in Ending the Opioid Epidemic
(2CEU, Issued June 2022, Course Expires June 30, 2025) Dental teams can help decrease opioid misuse through risk assessment, patient education, and treatment referrals. By Lisa Bilich, RDH, MS
(2CEU, Issued June 2022, Course Expires June 30, 2025) Using buffered articaine offers several clinical advantages in dental pain management. By Arthur C. DiMarco, DMD, and Kathy Bassett, RDH, MEd
(2CEU, Issued May 2022, Course Expires May 31, 2025) Clinicians should consider nonopioid analgesics when managing adolescent postoperative pain — especially given these patients’ risk for inappropriate substance use. By J. William Claytor Jr., DDS, MAGD
Rethinking the Use of Opioids in Moderate Sedation
(2CEU, Issued April 2022, Course Expires April 30, 2025) The risks associated with opioids can be greater than the benefits, so dentists should consider alternative strategies during minimal or moderate sedation. By Bryant W. Cornelius, DDS, MBA, MPH
Current Perspectives on Articaine in Dental Anesthesia
(2CEU, Issued March 2022, Course Expires March 31, 2025) This hybrid agent offers distinct benefits over other local anesthetic drugs. By Arthur C. DiMarco, DMD, and Kathy Bassett, RDH, MEd
Belmont Business Media is an ADA CERP-recognized provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ada.org/cerp.
Belmont Business Media Nationally Approved PACE Program Provider for FAGD/MAGD credit. Approval does not imply acceptance by any regulatory authority or AGD endorsement. July 1, 2021 to June 30, 2023. Provider ID 317924